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Abstract
Cicuta, M.E.; Roibón, W.R.; Barceló, M.C.; Arzú, O.R.; Amable, V.I.: Beta-lactam re-
sistance in enterobacteria isolated from animal and water. Rev. vet. 25: 1, 3-6, 2014. The 
susceptibility to β-lactam antibiotics was analysed in thirty seven strains of enterobacteria 
from both animals and non-chlorinated water of rural areas from Corrientes, North-eastern 
Argentina. Twenty nine were isolated from animals: Klebsiella  pneumoniae (n=9), Klebsi-
ella oxytoca (n=1), Proteus mirabilis (n=7), Escherichia coli (n=12), and 8 from non-chlori-
nated water: E. coli (n=5), K. pneumoniae (n=2), K. oxytoca (n=1). The antibiograms were 
performed by the Kirby-Bauer technique using antibiotic discs of ampicillin, cefotaxime, 
cefepime, piperacillin and with β-lactamases inhibitors: clavulanic acid-amoxicillin, sulbac-
tam-cefoperazone and tazobactam-piperacillin. Carbapenems with an EDTA disc as metallo 
β-lactamases inhibitor were also used. Neither phenotypically ESBL (extended-spectrum 
beta-lactamases) nor carbapenemase were detected. It can be inferred that the resistance 
observed in this assay may be attributed to a different source.
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Resumen
Cicuta, M.E.; Roibón, W.R.; Barceló, M.C.; Arzú, O.R.; Amable, V.I.: Sensibilidad de 
enterobacterias de origen animal y agua frente a antibióticos betalactámicos. Rev. vet. 
25: 1, 3-6, 2014. Se analizaron 37 cepas de enterobacterias, 29 provenientes de diferentes 
animales: Klebsiella  pneumoniae (n=9), Klebsiella oxytoca (n=1), Proteus mirabilis (n=7), 
Escherichia coli (n=12), así como 8 aisladas de aguas no clorinadas de perforaciones, pozos 
de balde y tanques rurales de diferentes lugares de la Provincia Corrientes (Argentina): E. 
coli (n=5), K. pneumoniae (n=2) y K. oxytoca (n=1). Con el fin de conocer su sensibilidad a 
antibióticos β-lactámicos se realizaron antibiogramas de acuerdo con el método de Kirby-
Bauer. Se utilizaron discos de ampicilina, cefotaxime, cefepime, piperacilina y con el agre-
gado de inhibidores de β-lactamasas: amoxicilina-clavulánico, cefoperazona-sulbactam y 
piperacilina-tazobactam. También fueron utilizados carbapenems con un disco de EDTA 
como inhibidor de metalo β-lactamasas . No se detectaron fenotípicamente β-lactamasas de 
espectro extendido ni carbapenemasa, por lo que se infiere que la resistencia observada se 
debió a mecanismos de diferente origen.
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INTRODUCTION
The most common mechanism by which bacteria 
are resistant to antibiotics is by producing enzymes that 
inactivate the drugs 1 . β-lactam antibiotics (penicillins 
and cephalosporins) can be inactivated by enzymes 
known as β-lactamases 1, 4 . Hundreds of β-lactamases 
have been described; they can be both plasmid or chro-
mosomic encoded, and have varying degrees of activ-
ity against the different β-lactam antibiotics 4 . Many 
bacteria produce multiple β-lactamases. In response to 
the proliferation and spread of β-lactamases, the phar-
maceutical industry has developed some β-lactam an-
tibiotics that are more resistant to hydrolysis by these 
enzymes 2 . In addition, some combination drugs have 
been produced which contain both a β-lactam antibi-
otic and a β-lactamase inhibitor; the inhibitor has high 
affinity for the β-lactamase enzyme, irreversibly binds 
to it, and thereby preserves the activity of the β-lactam 
antibiotic 10 . About one-tenth of isolates of gram-neg-
ative pathogens seem to produce extended-spectrum 
beta-lactamases (ESBL) 18 .
The phenotipic detection of ESBL are based in 
the inhibition of the majority of these enzymes by cla-
4vulanic acid and the utilization of 3º and 4º 
generation cephalosporins and aztreonam as 
indicators 18 . The double disc synergy proof 
consist to situate a clavulanic-amoxicillin disc 
next to β-lactam antibiotic discs as indicators. 
The ESBL production is demonstrated by en-
larging the inhibition halo of any indicator by 
the clavulanic acid action. The discs with in-
hibitors is one of the recommended methods of 
the Clinical Laboratory and Standards Insti-
tute 3 . This method consists in comparing a 3º 
or 4º generation cephalosporin-inhibition zone 
alone or with clavulanic acid. The activity in-
crease of cephalosporin in presence of clavu-
lanic acid indicates ESBL production. ESBL 
genes are frequently in the same plasmids that 
codifies aminoglucosid and sulfonamide re-
sistance. Some enterobacteria species posses 
changes that add quinolone resistance so that 
means multiresistance 10 . 
A mechanism founded in some species 
naturally transformed, had been described 
as β-lactam resistant, where penicillin bind-
ing proteins (PBP) were altered, presumably 
by transformation, with reduced affinity to 
β-lactam antibiotics 7, 15, 16 . The resistance to 
these, in the majority of Gram negative species 
and some Gram positive, is due to the presence 
of a β-lactamase, which modifies the antibiotic, 
avoiding its fixation to PBPs 18 . Drug efflux 
systems, pump out a broad range of chemi-
cally and structurally unrelated compounds 
from bacteria, in an energy-dependent manner, 
without drug alteration or degradation 13 . Al-
though drug efflux pumps are found in Gram-negative 
and Gram-positive bacteria, efflux mediated resistance 
in Gram-negative bacteria is a more complex prob-
lem due to the molecular architecture of the cell en-
velope 6, 9 . As a consequence, drug resistance in many 
cases is attributable to synergy between reduced drug 
intake (mainly due to low outer membrane permeabil-
ity) and active drug export (via efflux pumps) 11 .
Along with the steady increase of nosocomial in-
fection rates in veterinary clinics, particular attention 
has recently been drawn to the genetic background of 
multi-resistant strains, resulting in the identification 
of certain genetic lineages which frequently appear in 
both, human and animal samples: extended-spectrum 
β-lactamases (ESBL)-producing Enterobacteriaceae 14 . 
These sequence types (ST), include the pandemic ST131 
for ESBL-producing E. coli 18 .
The isolation of opportunistic Proteus mirabilis 
and Proteus vulgaris is very frequent in clinical sam-
ples from canine otitis at the Bacteriologic and Myco-
logic Diagnostic Laboratory of the Microbiology Area 
of the Veterinary Science Unit at National North East 
University of Corrientes, Argentina. In eight years 
(from 2006 to present) over 339 pathological samples, 
in 69 (20,3%) enterobacteria were isolated, from these, 
44 strains (63,7%) were Proteus spp, belonging to mi-
rabilis (n=33, 75%) and vulgaris (n=11, 25%) species, 
followed by Enterobacter spp (n=14, 20,3%), Klebsiella 
spp (n=7, 10,1%) and Escherichia coli (n=6, 8,7%). Oth-
er isolates were 38 strains, corresponding 12 to Entero-
bacter spp., 8 to E. coli and Proteus spp. respectively, 6 
to Klebsiella spp. and 4 to Citrobacter spp from 21 pu-
rulent exudates, 2 nasal, conjuntival and vaginal swabs 
each one, 2 faecal cultures and 2 urocultures. As we do 
not know the resistance of enterobacteriae from water 
we included those isolated from non-chlorinated water 
of rural area.
As the serine-β-lactamases, AmpCs, are induced 
and occur naturally in Enterobacter spp., C. freundii 
and S. marcescens 8, 12 , they were excluded of this study 
owing their intrinsic antimicrobial resistance (inherent 
or innate, not acquired) which is reflected in wild type 
antimicrobial patterns of all or almost all representa-
tive species 3 .
Owing that enterobacteria isolated from these 
pathological process presented resistance to different 
β-lactam antibiotics, the aim of the present work was 
to try phenotypically determined the origin of this, to 
establish susceptibility patterns of each genre in order 
to know the best options for treatment.
Table 1. Detail of 29 strains of Enterobacteria of animal origin.
Nº bacterial strain origin reference
1 Klebsiella pneumoniae  canine otitis Ex O 1031
2 Klebsiella pneumoniae  rabbit nasal exudate As 163
3 Klebsiella pneumoniae  mare vaginal discharge Ex V 129
4 Klebsiella pneumoniae  cat nasal discharge Ex N 86
5 Klebsiella pneumoniae  canine piodermitis Ex P 183
6 Klebsiella pneumoniae  canine piodermitis Ex P 190
7 Klebsiella pneumoniae  canine piodermitis Ex P 201
8 Klebsiella pneumoniae  canine piodermitis Ex P 204
9 Klebsiella pneumoniae  canine uroculture O 47
10 Klebsiella oxytoca  equine dermal ulcer U 163
1 Escherichia coli canine otitis Ex O 1056
2 Escherichia coli canine otitis Ex O 1060
3 Escherichia coli minced bovine meat C 441
4 Escherichia coli minced bovine meat C 448
5 Escherichia coli equine dermal ulcer U 162
6 Escherichia coli canine nasal discharge Ex N 91
7 Escherichia coli calf faecal swab MF 21
8 Escherichia coli calf faecal swab MF 28
9 Escherichia coli calf faecal swab MF 29
10 Escherichia coli calf faecal swab MF 30
11 Escherichia coli calf faecal swab MF 31
12 Escherichia coli deer liver As 165
1 Proteus mirabilis canine piodermitis ExP 177
2 Proteus mirabilis canine otitis Ex O 1011 
3 Proteus mirabilis canine otitis Ex O 1030
4 Proteus mirabilis canine otitis Ex O 1045
5 Proteus mirabilis equine dermal ulcer U 160
6 Proteus mirabilis equine dermal ulcer U 162
7 Proteus mirabilis ant-bear fecal swab AS 164
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5MATERIAL AND METHODS
Thirty seven strains of enterobacteria, 29 from 
clinical samples (Table 1) and 8 from non-chlorinated 
water of rural areas of Corrientes Province, at North 
East of Argentina: E. coli (n=5), K. pneumoniae (n=2) 
and K. oxytoca (n=1), were studied for their suscepti-
bility to β-lactam antibiotics using antibiotic-diffusion 
on Mueller-Hinton agar by Kirby-Bauer antibiogram 3 . 
Antibiotic discs (Britania®) of ampicillin (Ampi 
10 μg), cefotaxime (Cftx 30 μg), cefepime (Fep 30 μg), 
piperacillin (Pip 100 μg) and with β-lactam inhibitors: 
clavulanic acid-amoxicillin (CAM 20/10 μg), sulbac-
tam-cefoperazone (S-Cfpz 75/30 μg) and tazobactam-
piperacillin (TAZ 100/10 μg) were used. To detect ex-
tended spectrum β-lactamases (ESBL) strains which 
hidrolyzed 3ª generation cephalosporins (Cftx, ceftazi-
dime Caz 30 μg) as well as the monobactam aztreonam 
(Azt 30 μg) and those inhibited by CAM but not by ce-
foxitin (Fox 30 μg) were observed; boronic acid discs 
(Bor) were also used because its hability to inhibit plas-
midic AmpC serin β-lactamases (AmpCp) with 3º gen-
eration Cfp as indicators 17 . 
The strains were also analysed to phenotypically 
determine the presence of metallo-β-lactamase (MBL): 
monodiscs of the carbapenems imipenem (Im, 10 μg) 
and meropenem (Mer, 10 μg) with one of ethilendi-
aminotetraacetic acid (EDTA, 1 μmol) acting as MBL 
inhibitor were used according the agar diffusion meth-
od 6 . The test is positive when there is synergism be-
tween EDTA and carbapenem discs.
RESULTS
All strains of Proteus mirabilis (7/7, 100%) and 5/16 
(31,2%) of E. coli were resistant to ampicillin. With the 
aggregate of clavulanic acid to amoxicyllin (CAM) 
they turned susceptible in 71,4 and 87,5 % respectively. 
Four strains of P. mirabilis were simultaneously re-
sistant to Ampi and Cftx and susceptible to CAM and 
S-Cfpz; two strains of K. pneumoniae and one E. coli 
resistant to Pip were sensible to TAZ. With respect to 
E. coli, 3/16 were resistant to Ampi and susceptibly to 
CAM and presented simultaneous resistance to Cftx 
and Azt. There was not observed enlarged inhibition 
halo for ESBL phenotypic detection in these strains.
Cefoxitin resistance was present in K. pneumoniae 
(3/11, 27,2%) and P. mirabilis (3/7, 42,8%) that natural-
ly lack the AmpC gene. Metallo β-lactamases were not 
detected in these strains although resistance to imipen-
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Figure 1. K. oxytoca from canine piodermitis resistant 
to Cftx, Azt, CAM and Fox.
Figure 2. P. mirabilis  from equine dermal ulcer resis-
tant to Azt, Cftx and CAM.
Figure 3. K. pneumonaie from equine adenitis resistant 
to Im, Fox, Azt and Cftx.
Figure 4. E. coli from bovine minced meat resistant to 
Im, Fox and CAM and susceptibily to other β-lactams.
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Abbreviations: CAM: clavulanic acid-amoxycillin, Pip: Piperacillin, TAZ: Tazobactam-piperacillin, Ctx: Cefo-
taxime, Fox: Cefoxitin, Caz: Ceftazidime, Fep: Cefepime, S-Cfpz: Sulbactam-cefoperazone, Im: Imipenem, Mer: 
Meropenem, Azt: Aztreonam, Bor: Boronic acid, EDTA: Ethilendiaminotetraacetic acid.
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6em, was observed in 9 of them: 3 K. pneumoniae, 3 E. 
coli and 3 P. mirabilis, all of animal origin. 
DISCUSSION
Cefoxitin resistance found in this work in bacterias 
like K. pneumoniae and P. mirabilis that naturally lack 
the AmpC gene, may be a sign of the presence of plas-
midic AmpC of epidemiological importance because 
its facility to horizontal dissemination. One character-
istic of chromosomic type AmpC β-lactamases is that 
they have no effect on 4º generation cephalosporins 
neither on carbapenems so they are the β-lactam antibi-
otic of therapeutic election. 
As there was not detected ESBL, it is concluded 
that the mechanisms of resistance may be produced by 
means of altered PBP that reduce affinity to β-lactam 
antibiotics as well as the synergy between reduced 
drug intake and active efflux pumps.
As the phenotypic screening was also negative for 
detecting metallo-β-lactamases (MBLs) producing 
isolates, the resistance to imipenem observed in nine 
strains, was more likely due to a decrease in the expres-
sion of an outer membrane protein channel for imipen-
em 11 . Owing that MBLs do not efficiently hydrolyze 
aztreonam, its sensibility would be a good predictor of 
the enzyme presence in resistant bacteria to imipenem 
and meropenem 5 . This was not the case in this work, 
where all the strains susceptible to aztreonam were also 
susceptibly to meropenem. 
We agree with authors that interdisciplinary ap-
proaches including human and veterinary experts 
should be implemented to develop reliable investigation 
procedures with respect to the current reality of animal 
owners and their pets 18 . Additionally, consequent ba-
sic hygienic measures, prudent use of antimicrobials in 
companion animals and efforts regarding implementa-
tion of antibiotic stewardships should be fostered.
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